skip to main content
Results 1 2 3 4 5 next page
Refined by: collection: John Libbey Eurotext Journals remove language: French remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Atezolizumab (Tecentriq ® ): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma
Material Type:
Article
Add to e-Shelf

Atezolizumab (Tecentriq ® ): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma

Bernard-Tessier, Alice ; Bonnet, Clément ; Lavaud, Pernelle ; Gizzi, Marco ; Loriot, Yohann ; Massard, Christophe

Bulletin du cancer, 2018-02, Vol.105 (2), p.140 [Peer Reviewed Journal]

France

No full-text

2
Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions
Material Type:
Article
Add to e-Shelf

Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions

Penel, Nicolas ; Ryckewaert, Thomas ; Orbach, Daniel

Bulletin du cancer, 2020-03, Vol.107 (3), p.375 [Peer Reviewed Journal]

France

No full-text

3
Doubling complete histological response in sarcomas with radiation therapy using nanoparticles (Hafnium oxide, NBTXR3), a phase III trial
Material Type:
Article
Add to e-Shelf

Doubling complete histological response in sarcomas with radiation therapy using nanoparticles (Hafnium oxide, NBTXR3), a phase III trial

Khalladi, Nazim ; Thariat, Juliette

Bulletin du cancer, 2019-12, Vol.106 (12), p.1070 [Peer Reviewed Journal]

France

No full-text

4
Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores
Material Type:
Article
Add to e-Shelf

Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores

Greilsamer, Charlotte ; Campion, Loïc ; Cabart, Mathilde ; Gourmelon, Carole ; Senellart, Hélène ; Bennouna, Jaafar

Bulletin du cancer, 2018-10, Vol.105 (10), p.896 [Peer Reviewed Journal]

France

No full-text

5
Phases 0, 1 and 2 oncology clinical trials: current questions
Material Type:
Article
Add to e-Shelf

Phases 0, 1 and 2 oncology clinical trials: current questions

Penel, N ; Fournier, C ; Stéphanie, C

Bulletin du cancer, 2010-01, Vol.97 (1), p.55 [Peer Reviewed Journal]

France

No full-text

6
Dbait: An innovative concept to inhibit DNA repair and treat cancer
Material Type:
Article
Add to e-Shelf

Dbait: An innovative concept to inhibit DNA repair and treat cancer

Biau, Julian ; Devun, Flavien ; Verrelle, Pierre ; Dutreix, Marie

Bulletin du cancer, 2016-03, Vol.103 (3), p.227 [Peer Reviewed Journal]

France

No full-text

7
Osimertinib (Tagrisso ® ): Activity, indication and modality of use in non-small cell lung cancer
Material Type:
Article
Add to e-Shelf

Osimertinib (Tagrisso ® ): Activity, indication and modality of use in non-small cell lung cancer

Giroux Leprieur, Etienne ; Cortot, Alexis B ; Cadranel, Jacques ; Wislez, Marie

Bulletin du cancer, 2016-10, Vol.103 (10), p.815 [Peer Reviewed Journal]

France

No full-text

8
The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB
Material Type:
Article
Add to e-Shelf

The role of the expansion cohort in phase I trials in oncology: guidelines of the phase I HUB

Ezzalfani, Monia ; Dugué, Audrey ; Mollevi, Caroline ; Pulido, Marina ; Bonnetain, Franck ; Filleron, Thomas ; Gal, Jocelyn ; Gauthier, Mélanie ; Le Deley, Marie Cécile ; Le Tourneau, Christophe ; Médioni, Jacques ; Nguyen, Jean-Michel ; Chabaud, Sylvie ; Teixeira, Luis ; Thivat, Emilie ; You, Benoît ; Kramar, Andrew ; Paoletti, Xavier

Bulletin du cancer, 2015-01, Vol.102 (1), p.73 [Peer Reviewed Journal]

France

No full-text

9
New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer
Material Type:
Article
Add to e-Shelf

New drug approval: Dostarlimab - second line in advanced MSI endometrial cancer

Galienne, Maxime ; Rodrigues, Manuel

Bulletin du cancer, 2021-07, Vol.108 (7-8), p.675 [Peer Reviewed Journal]

France

No full-text

10
Drug approval: Selpercatinib and pralsetinib - RET-altered non-small cell lung cancer
Material Type:
Article
Add to e-Shelf

Drug approval: Selpercatinib and pralsetinib - RET-altered non-small cell lung cancer

Courtier, Baudouin ; Pierret, Thomas

Bulletin du cancer, 2021-06, Vol.108 (6), p.562 [Peer Reviewed Journal]

France

No full-text

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Full Text Online (160)
  2. Peer-reviewed Journals (442)

Refine My Results

Resource Type 

  1. Articles  (443)
  2. Conference Proceedings  (3)
  3. More options open sub menu

Creation Date 

From To
  1. Before1982  (36)
  2. 1982To1992  (45)
  3. 1993To2002  (119)
  4. 2003To2013  (137)
  5. After 2013  (110)
  6. More options open sub menu

Language 

  1. English  (38)
  2. Spanish  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far